Bank of New York Mellon Corp Sells 227,357 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Bank of New York Mellon Corp trimmed its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 8.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,359,850 shares of the company’s stock after selling 227,357 shares during the period. Bank of New York Mellon Corp owned 1.97% of Privia Health Group worth $46,135,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Park Avenue Securities LLC raised its position in shares of Privia Health Group by 3.8% during the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after purchasing an additional 532 shares during the period. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after purchasing an additional 632 shares during the period. KBC Group NV raised its position in shares of Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares during the period. Fifth Third Bancorp raised its position in shares of Privia Health Group by 38.3% during the 4th quarter. Fifth Third Bancorp now owns 5,105 shares of the company’s stock valued at $100,000 after purchasing an additional 1,415 shares during the period. Finally, Choreo LLC raised its position in shares of Privia Health Group by 8.7% during the 4th quarter. Choreo LLC now owns 21,841 shares of the company’s stock valued at $425,000 after purchasing an additional 1,752 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on PRVA. JPMorgan Chase & Co. raised their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Piper Sandler raised their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. JMP Securities reaffirmed a “market outperform” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Friday, February 14th. Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company. Finally, Stephens reaffirmed an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Privia Health Group presently has a consensus rating of “Buy” and an average target price of $26.47.

Privia Health Group Stock Up 0.7 %

Shares of NASDAQ:PRVA opened at $25.69 on Thursday. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04. The stock has a market capitalization of $3.08 billion, a P/E ratio of 256.93, a PEG ratio of 3.47 and a beta of 0.87. The firm has a fifty day simple moving average of $22.73 and a two-hundred day simple moving average of $20.72.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.